Amylyx Pharmaceuticals Statistics
NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
27.43-0.61 (-2.18%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Amylyx Pharmaceuticals by the numbers
Amylyx Pharmaceuticals has a market capitalization of $3.44 billion based on 125.51M shares outstanding. With trailing EPS of $-1.38, Amylyx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.6% below its 50-day average and 46.9% above its 200-day average.
Average daily trading volume is 2.33M shares, or about $63.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMLX valuation vs. peer median
| Metric | AMLX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.44B | $3.59B | -4% |
| Avg. volume | 2.33M | 2.11M | +11% |
Peer median across 8 companies: IDYA, ACAD, XENE, PBLS, OGN, VKTX, TNGX, LEGN.
Valuation
- Market cap
- $3.44B
- EPS (TTM)
- $-1.38
- Shares outstanding
- 125.51M
Price and trading
- Previous close
- 28.04
- Open
- 27.72
- Day range
- 27.21 – 28.46
- 52-week range
- 10.83 – 41.14
- 52-week change
- +103.34%
- Beta
- —
- Volume
- 2.06M
- Average volume
- 2.33M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.44B
- Forward Pe
- -23.76
- Eps
- -1.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 41.14
- Week52 Low
- 10.83
- Avg Volume
- 2.33M
- Shares Outstanding
- 125.51M
- Ma50
- 29.69
- Ma200
- 18.67
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -33.33%
- Pct From52w Low
- 153.28%